Suchergebnisse - "Gupta, Neeraj"

PubPharm (650)

41

Formula milk companies and allergy healthcare professionals in India

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Allen, H. | Gupta, A. | Mundell, A. | +6

42

Systematic rotation versus continuous application of 'nasal prongs' or 'nasal mask' in preterm infants on nCPAP : a randomized controlled trial

enthalten in: European journal of pediatrics | 2023

von Gautam, G. | Gupta, N. | Sasidharan, R. | +4

43

Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus? : Neonatologist's Viewpoint

enthalten in: Indian pediatrics | 2023

von Gupta, N.

CommentIn: Indian Pediatr. 2023 Sep 15;60(9):772. - PMID 37705273

44

Brigatinib pharmacokinetics in patients with chronic hepatic impairment

enthalten in: Investigational new drugs | 2023

von Hanley, M. | Kerstein, D. | Tugnait, M. | +4

45

Seizure EEG Quality in Right Unilateral Ultrabrief ECT

enthalten in: The journal of ECT | 2023

von Yeap, S. | Gupta, N. | Gill, S. | +2

46

Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?

enthalten in: Indian pediatrics | 2023

von Kumar, A. | Dutta, S. | Gupta, N. | +1

47

Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?

enthalten in: Indian pediatrics | 2023

von Kumar, A. | Dutta, S. | Gupta, N. | +1

48

Flexible Fiberoptic Bronchoscopy in Non-ventilated Children in Pediatric Intensive Care Unit : Utility, Interventions and Safety

enthalten in: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2023

von Sachdev, A. | Gupta, N. | Khatri, A. | +4

49

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors

enthalten in: Journal of clinical pharmacology | 2023

von Hanley, M. | D'Arcangelo, M. | Felip, E. | +5

50

Correction to : A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Kim, R. | Leal, A. | Parikh, A. | +9

ErratumFor: Cancer Chemother Pharmacol. 2023 Apr;91(4):291-300. - PMID 36738333